These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15973133)

  • 1. Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents.
    Marzola P; Ramponi S; Nicolato E; Lovati E; Sandri M; Calderan L; Crescimanno C; Merigo F; Sbarbati A; Grotti A; Vultaggio S; Cavagna F; Lorusso V; Osculati F
    Invest Radiol; 2005 Jul; 40(7):421-9. PubMed ID: 15973133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.
    Boschi F; Marzola P; Sandri M; Nicolato E; Galiè M; Fiorini S; Merigo F; Lorusso V; Chaabane L; Sbarbati A
    MAGMA; 2008 May; 21(3):169-76. PubMed ID: 18317830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
    Cyran CC; Sennino B; Chaopathomkul B; Fu Y; Rogut V; Shames DM; Wendland MF; McDonald DM; Brasch RC
    Invest Radiol; 2008 May; 43(5):298-305. PubMed ID: 18424950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent.
    Wikström MG; Moseley ME; White DL; Dupon JW; Winkelhake JL; Kopplin J; Brasch RC
    Invest Radiol; 1989 Aug; 24(8):609-15. PubMed ID: 2777530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced MRI of murine sponge model for progressive angiogenesis assessed with gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1).
    Ramponi S; Rebaudengo C; Cabella C; Grotti A; Vultaggio S; Aime S; Morisetti A; Lorusso V
    J Magn Reson Imaging; 2008 Apr; 27(4):872-80. PubMed ID: 18383249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution.
    Furman-Haran E; Margalit R; Maretzek AF; Degani H
    J Magn Reson Imaging; 1996; 6(1):195-202. PubMed ID: 8851428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.
    Anemone A; Consolino L; Longo DL
    Eur Radiol; 2017 May; 27(5):2170-2179. PubMed ID: 27572810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
    Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
    Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.
    Cyran CC; Fu Y; Raatschen HJ; Rogut V; Chaopathomkul B; Shames DM; Wendland MF; Yeh BM; Brasch RC
    J Magn Reson Imaging; 2008 Mar; 27(3):581-9. PubMed ID: 18219614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors.
    Turetschek K; Huber S; Helbich T; Floyd E; Tarlo KS; Roberts TP; Shames DM; Wendland MF; Brasch RC
    Acad Radiol; 2002 May; 9 Suppl 1():S112-4. PubMed ID: 12019843
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors].
    Raatschen HJ; Fu Y; Rogut V; Simon GH; Sennino B; Wolf KJ; Brasch RC
    Rofo; 2010 Feb; 182(2):133-9. PubMed ID: 19862658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.